We have investigated the interaction between monomers of the dimeric yeast cytochrome bc 1 complex by analyzing the pre-steady and steady state activities of the isolated enzyme in the presence of antimycin under conditions that allow the first turnover of ubiquinol oxidation to be observable in cytochrome c 1 reduction. At pH 8.8, where the redox potential of the iron-sulfur protein is ϳ200 mV and in a bc 1 complex with a mutated iron-sulfur protein of equally low redox potential, the amount of cytochrome c 1 reduced by several equivalents of decyl-ubiquinol in the presence of antimycin corresponded to only half of that present in the bc 1 complex. Similar experiments in the presence of several equivalents of cytochrome c also showed only half of the bc 1 complex participating in quinol oxidation. The extent of cytochrome b reduced corresponded to two b H hemes undergoing reduction through one center P per dimer, indicating electron transfer between the two cytochrome b subunits. Antimycin stimulated the ubiquinolcytochrome c reductase activity of the bc 1 complex at low inhibitor/enzyme ratios. This stimulation could only be fitted to a model in which half of the bc 1 dimer is inactive when both center N sites are free, becoming active upon binding of one center N inhibitor molecule per dimer, and there is electron transfer between the cytochrome b subunits of the dimer. These results are consistent with an alternating half-of-the-sites mechanism of ubiquinol oxidation in the bc 1 complex dimer.
The cytochrome bc 1 complex transfers electrons from ubiquinol to cytochrome c by the protonmotive Q cycle mechanism (1) in which there are two substrate-binding sites where ubiquinol is oxidized (center P) and ubiquinone is re-reduced (center N). Crystal structures of the bc 1 complexes obtained from various sources (2-4) show a dimeric structure in which the two ironsulfur protein subunits span both monomers in an intertwined arrangement. Crystal structures from the yeast bc 1 complex show ubiquinone at center N of only one monomer and cytochrome c also in only one monomer, suggesting a functional asymmetry in the dimer (5) .
Some center P inhibitors have been shown to completely block bc 1 complex activity upon binding to only half of the dimeric complex (6) , suggesting anti-cooperative interaction between the ubiquinol oxidation sites in the dimer. Antimycin, a center N inhibitor, binds to only one center N of the dimeric enzyme in a mutant where the iron-sulfur cluster cannot be inserted into the Rieske protein, suggesting conformational interaction between centers P and N of different monomers (7) . In addition, it has long been observed that titration of the cytochrome c reductase activity of the enzyme with antimycin yields non-linear curves (8, 9) , which is unexpected for a tightly bound inhibitor. This anomalous behavior has been attributed to rapid mobility of the inhibitor between the two center N sites in the dimer (10) , although an alternate explanation could be equilibration of electrons between the cytochrome b subunits (6) .
In this work, we have analyzed the pre-steady and steady state kinetics of the isolated yeast bc 1 complex in the presence of antimycin under conditions where the simultaneous detection of both electrons coming from the first ubiquinol oxidation at center P is possible. The results show that the number of center N sites blocked in the dimer determines whether ubiquinol oxidation can occur in one or both of the monomers, and that electron communication exists between cytochrome b subunits of the two monomers.
EXPERIMENTAL PROCEDURES

Materials-Yeast nitrogen base (YNB)
1 without amino acids and with ammonium sulfate was obtained from U.S. Biological. Amino acids were from Aldrich, Sigma, Fluka, and ICN. Dodecylmaltoside was obtained from Roche Applied Science. DEAE-Bio-Gel was obtained from Bio-Rad. Antimycin, diisopropyl fluorophosphate, phenylmethylsulfonyl fluoride, horse heart cytochrome c, decyl-ubiquinone, sodium ascorbate, and dithionite were purchased from Sigma. Decyl-ubiquinol was prepared as described (11) . Antimycin and decyl-ubiquinol were quantified by UV-spectroscopy (6) using extinction coefficients of 4.8 mM Ϫ1 cm Ϫ1 at 320 nm (12) and 4.14 mM Ϫ1 cm Ϫ1 at 289 nm (13) , respectively. Purification of Cytochrome bc 1 Complexes-Wild-type bc 1 complex was isolated from Red Star cake yeast as described previously (14, 15) . The bc 1 complex with a Y185F mutation in the iron-sulfur protein was isolated from the iron-sulfur protein deletion strain JPJ1 (16) complemented with the single-copy plasmid pEDRIP1-Y185F encoding ironsulfur protein with the Y185F mutation (17) . This strain was grown on synthetic dropout medium containing 0.7% YNB, 0.14% amino acid mix lacking tryptophan, and 2% dextrose as previously described (18) . The bc 1 complex was purified by the same procedure as used with the wild-type enzyme (14, 15) . Quantification of the bc 1 complexes was performed as described previously (6), using extinction coefficients of 17.5 mM Ϫ1 cm Ϫ1 at 553-539 for cytochrome c 1 (19) and 25.6 mM Ϫ1 cm
Ϫ1
at 563-578 for cytochrome b heme (8) .
Pre-steady State Reduction of bc 1 Complexes-Pre-steady state reduction of the cytochrome bc 1 complexes was followed at room temperature by stopped flow rapid scanning spectroscopy using the OLIS Rapid Scanning Monochromator as described before (15) . When using the wild-type bc 1 complex, reactions were started by rapid mixing of 3 M enzyme in assay buffer containing 50 mM Tris-HCl, pH 8.8, 250 mM sucrose, 1 mM sodium azide, 0.2 mM EDTA, and 0.05% Tween 20 against * This work was supported by National Institutes of Health Research Grant GM 20379. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. an equal volume of the same buffer containing different concentrations of decyl-ubiquinol. For measurements using the bc 1 complex with the Y185F mutation in the iron-sulfur protein, Tris was replaced by 50 mM potassium phosphate, pH 7.0, in the assay medium.
For each experiment, 6 -8 data sets were averaged, and the oxidized spectrum was subtracted. The time course of absorbance change at 539, 554, 563, and 578 nm was extracted using software from OLIS and exported to the Origin 5.0 program (OriginLab Corp.). By comparing the dithionite and ascorbate-reduced spectra of the yeast bc 1 complex, it was determined that cytochrome b reduction results in a 30% increase in the absorbance change at 554 -539 nm used for monitoring cytochrome c 1 reduction, as shown in Fig. 1 . A similar value was obtained by deconvoluting the dithionite-reduced spectra into two components by fitting to a double Lorentzian function (not shown). Considering that the final concentration of cytochrome c 1 in the pre-steady state experiments was 1.5 M and that the path length of the mixing chamber is 2 cm, complete reduction of cytochrome b would induce an extra 0.016 absorbance change at 554 -539. Therefore, since the absorbance at 563 nm of fully reduced cytochrome b would be 0.154, a correction factor of (⌬A 563-578 nm/0.154) ϫ 0.016 was subtracted from ⌬A 554 -539 nm at each time point to obtain the absorbance change attributable to cytochrome c 1 . The contribution of cytochrome c 1 at the wavelengths used for cytochrome b calculation (563-579 nm) was considered to be negligible from a comparison of the dithionite-reduced and the dithionite minus ascorbate-reduced spectra (Fig. 1) . The absorbance changes of cytochrome c 1 and b were fitted to either a monophasic or a biphasic exponential function in the Origin program.
Pre-steady State Reduction of Exogenous Cytochrome c-The same procedure was followed as described above for the isolated bc 1 complex except that 18 M horse heart cytochrome c and 1 mM KCN were added to the assay buffer containing the bc 1 complex before rapid mixing. The time course of absorbance change at 550 -539 nm was not corrected for cytochrome b reduction as judged by the negligible contribution of the b hemes at this wavelength pair (see Fig. 1 ). The absorbances for cytochrome c and b were fitted in the Origin program to a monophasic or biphasic exponential function. Cytochrome c reduction was quantified using an extinction coefficient of 21.5 mM Ϫ1 cm Ϫ1 at 550 -539 nm (20) . Ubiquinol-Cytochrome c Reductase Activity Assays-Ubiquinol-cytochrome c reductase activity was measured by stopped flow spectroscopy using the OLIS Rapid Scanning Monochromator as described elsewhere (6) . Antimycin was added incrementally to a 1 mM bc 1 complex solution in assay buffer containing 50 mM phosphate, pH 7.0, 250 mM sucrose, 1 mM sodium azide, 0.2 mM EDTA, and 0.05% Tween 20 at 4 o . After 4 min, the antimycin-bc 1 complex mixture was diluted to a concentration of 100 nM of enzyme in assay buffer at room temperature with 1 mM potassium cyanide and 40 M decyl-ubiquinol. After two more minutes, the reaction was started by mixing against an equal volume of 60 M cytochrome c in assay buffer. The non-enzymatic rate of reduction of cytochrome c by decyl-ubiquinol was obtained by mixing equal volumes of 60 M cytochrome c in assay buffer against 40 M decyl-ubiquinol in assay buffer, and was found to be negligible. The reaction was followed for 2 s. For each inhibitor concentration, six data sets were obtained, and the time course of cytochrome c reduction was extracted using the OLIS software. The rate of cytochrome c reduction was calculated from the absorbance increase at 550 -539 nm, using an extinction coefficient of 21.5 mM Ϫ1 cm Ϫ1 (20) . Kinetic Modeling-For simulations of pre-steady state reduction of cytochrome c 1 , cytochrome b, and exogenous cytochrome c, the Dynafit program (Biokin Ltd.) was used (21) . Dynafit allows simulation and fitting of either the initial velocities or the time course of enzyme reactions to different molecular mechanisms represented symbolically by a set of chemical equations. Rate constants and concentrations of enzyme and ligands can be allowed to vary during iterative fitting in order to obtain adjusted values. The scripts used for simulations are provided as Supplemental Data.
Forward and reverse rate constants were assigned to each equation representing a reversible partial reaction. The slowest rate constant was assigned to the ubiquinol oxidation reaction at center P, while all other constants were assumed to be several orders of magnitude faster (17) . This rate constant was determined by iterative fitting allowing only this parameter along with the off rate constants for decyl-ubiquinol binding to vary. Although the precise values of the individual non-ratelimiting constants are irrelevant to the result of the simulation or fitting, the ratio of the reverse/forward rates was chosen to correspond to the equilibrium constants calculated to exist under the experimental conditions used.
For experiments with wild-type bc 1 complex at pH 8.8 in the presence of excess antimycin, the redox potential (E m ) of decyl-ubiquinol was calculated to be Ϫ16 mV assuming a ⌬E m of 59 mV/pH unit with respect to an E m7 of 90 mV. The iron-sulfur protein E m was calculated to be 200 mV using the known ⌬E m of the Rieske cluster as a function of pH (22) , taking as a reference an E m7 of 285 mV (23) . Assuming a pH-independent E m of 65 mV for b H (23) , an average E m value of 132.5 mV is obtained for the electron acceptors in a concerted ubiquinol oxidation reaction (the electron transfer between b L and b H was obviated to simplify the mechanism). With a ⌬E m of 148.5 mV between decylubiquinol and the redox acceptors, an equilibrium constant of 18 was calculated for the first turnover at center P according to the Nernst equation. Using a E m of Ϫ20 mV for heme b L (23), K eq for the second turnover at center P is 8 in the presence of antimycin and assuming no electron equilibration between monomers. For simulations with the bc 1 complex with a Y185F mutation in the iron-sulfur protein, E m7 values of 215 mV for iron-sulfur protein (17) and of 90 mV for decyl-ubiquinol were used, yielding K eq values of 2.2 and 1 for the first and second turnovers at center P without electron crossover between cytochrome b subunits. For electron transfer between iron-sulfur protein and cytochrome c 1 (E m ϭ 270 mV, Ref. 23), a K eq of 4 was used. Electron transfer between cytochrome c 1 and horse heart cytochrome c was assumed to occur with K eq ϭ 1.
For decyl-ubiquinol and decyl-ubiquinone binding, the on rate constants were fixed arbitrarily to the same value. Iterative fitting allowing the off rate constants to vary while all other parameters were fixed resulted in 2-fold higher values for decyl-ubiquinol than for decylubiquinone. For simulations in the presence of exogenous cytochrome c, extra steps were included in the mechanism to account for a slow antimycin insensitive rate of cytochrome c reduction. The reactions included assume the formation of semiquinone upon reduction of ironsulfur protein, dissociation of the semiquinone and dismutation to decyl-ubiquinone. The rate of dismutation was arbitrarily fixed to a very high rate, and the reverse reaction of semiquinone formation at center P was also set to yield a K eq of 0.001.
The rate constant for semiquinone dissociation from center P was then determined by iterative fitting. The values obtained were ϳ4 times lower than the off-rate constant for decyl-ubiquinone. However, the fitted dissociation rate constant for semiquinone became larger if K eq for semiquinone formation was set to an even lower value, or if the dismutation rate was increased. Therefore, the actual affinity for semiquinone at center P cannot be determined independently of the two other parameters that influence the stability of semiquinone. Nevertheless, the chosen parameters resulted in good fitting of the antimycininsensitive rate of cytochrome c reduction. For cytochrome c binding, a K d of 30 M was chosen, and the individual on and off rate constants were arbitrarily set.
Simulation of the relative concentrations of free enzyme and enzymeinhibitor complexes as a function of antimycin/bc 1 complex ratios was performed in Dynafit assuming no cooperativity in the binding of the inhibitor to the second monomer in the dimer. The K d for antimycin was FIG. 1. Absorption spectra of ascorbate-reduced and dithionite-reduced cytochrome bc 1 complex showing the spectral contribution of cytochrome b at 554 -539 nm. Cytochrome bc 1 complex isolated from wild-type yeast was suspended at 3 M concentration and incubated with 6 M antimycin in assay buffer at pH 7. Cytochrome c 1 was reduced with a few grains of sodium ascorbate and the reduced minus oxidized spectrum was recorded (dashed line). Dithionite was added to fully reduce the bc 1 complex and the dithionite minus oxidized spectrum was recorded (solid line). The calculated difference between the dithionite-and ascorbate-reduced spectra is shown by the dotted line. The absorbance due to cytochrome b at 554 nm is 0.0158, which is ϳ30% of the 0.052 A recorded at this wavelength for the ascorbatereduced cytochrome c 1 . Spectra were normalized to A ϭ 0 at 539 nm.
arbitrarily set to 0.2 nM, based on apparently stoichiometric binding of the inhibitor to the yeast bc 1 complex in assays with the enzyme concentration at 2 nM (6). The initial rates of cytochrome c reduction as a function of antimycin concentration were also fitted to different models using Dynafit scripts included as Supplemental Data.
RESULTS
Pre-steady State Reduction of Cytochrome c 1 by
Decyl-ubiquinol in the Presence of Antimycin-At pH 7 the E m of the ironsulfur protein in the bc 1 complex from wild-type yeast is ϳ15 mV higher than that of cytochrome c 1 . Consequently, oxidation of ubiquinol at center P does not result in more that 40% cytochrome c 1 reduction during the first turnover of the enzyme, since the electron that is transferred from the quinol to the high potential acceptors, iron-sulfur protein, and cytochrome c 1 , equilibrates primarily to the former. However, at pH 8.8, the E m of the iron-sulfur protein is about 70 mV lower than that of cytochrome c 1 . Therefore, at pH 8.8 a first turnover of ubiquinol oxidation at center P should result in the reduction of ϳ80% of the total content of cytochrome c 1 . However, in the presence of antimycin, as shown in Fig. 2 , no more than 50% of the total cytochrome c 1 underwent reduction even in the presence of 4 equivalents of decyl-ubiquinol. When one equivalent of substrate was available, only ϳ40% of cytochrome c 1 was reduced in a single phase, while kinetic simulations (dashed lines in Fig. 2 ) show that a 65% reduction level is expected. With 2 and 4 equivalents of decyl-ubiquinol, after the reduction of 40%, an additional 10% of c 1 was reduced with a slower rate. In contrast, kinetic modeling showed that over 90% of c 1 should be reduced, assuming that all of the bc 1 complex present is active. Interestingly, the reduction levels of c 1 could be accurately simulated assuming that only half of the bc 1 complex is participating in decyl-ubiquinol oxidation (solid lines in Fig. 2 ). In the absence of antimycin, up to 80% reduction of c 1 is observed with 2 equivalents of decyl-ubiquinol (Fig. 2C) , indicating that the proportion of permanently inactive bc 1 complex due to denaturation is not more than 20%. The fact that complete reduction of c 1 was not observed at any decyl-ubiquinol concentration is probably due to decyl-ubiquinol binding to center N, thereby reducing heme b H or blocking its reoxidation. This was confirmed by monitoring the reduction level of cytochrome b in the absence of antimycin, which showed a complete inhibition of the reoxidation phase at concentrations above 2 equivalents of decyl-ubiquinol (data not shown).
Even in the presence of a 10-fold molar excess of decylubiquinol, only 55% of cytochrome c 1 was reduced after several minutes in the presence of antimycin (Fig. 3B ), in contrast with the more than 90% reduction level reached in the absence of the inhibitor (Fig. 3A) . The kinetics of c 1 reduction without antimycin showed that most of this cytochrome c 1 was reduced in the second slow phase (data not shown), indicating that inhibition of cytochrome b reoxidation at center N by decyl-ubiquinol becomes considerable at this high substrate concentration.
Similar results were obtained using the bc 1 complex with a Y185F mutation in the iron-sulfur protein (Fig. 4) . The ironsulfur protein E m in this bc 1 complex has a value of 215 mV at pH 7 (17), almost the same as that of the iron-sulfur protein in the wild-type enzyme at pH 8.8. Consequently, 80% of cytochrome c 1 is expected to be reduced, assuming every center P is able to turn over once. This should occur with 2 or more equivalents of decyl-ubiquinol, according to kinetic modeling (Fig. 4,  dashed lines) . However, not even a 4-fold excess of substrate resulted in the reduction of more than ϳ40% of the c 1 , in agreement with simulations that assume that only half of the bc 1 complex is active in the presence of antimycin (solid lines). As in the case of the bc 1 complex from wild-type yeast, over 80% of the enzyme with the Y185F mutation in the iron-sulfur protein was active in the absence of inhibitor, according to the level of c 1 reduction with 1 and 2 equivalents of decyl-ubiquinol (Fig. 4, B and C) . Since at pH 7 the E m of decyl-ubiquinol is over 100 mV higher than at pH 8.8, reduction of heme b H by the quinol through center N was decreased (data not shown), resulting in a greater amount of c 1 reduction in the bc 1 complex with the Y185F iron-sulfur protein at pH 7.0 at low substrate concentrations as compared with wild-type enzyme at pH 8.8. In addition, only monophasic reduction kinetics were observed in the presence of antimycin, indicating that only one turnover per active center P occurred with up to 4 substrate equivalents.
Pre-steady State Reduction of Cytochrome b by Decyl-ubiquinol in the Presence of Antimycin-Given that for every electron transferred from ubiquinol to iron-sulfur protein and cytochrome c 1 one electron is observable in cytochrome b, the extent of reduction of this cytochrome in the presence of antimycin can also indicate the relative proportion of active enzyme. Furthermore, the extinction coefficients of each of the two b hemes are different; b H reduction contributes 70% of the total absorbance change when cytochrome b is completely reduced, and b L the remaining 30% (24) . The equilibrium constant of electron sharing between the two b hemes is largely displaced toward b H due to a ⌬E m Ͼ90 mV between the two redox centers (23) . This implies that when cytochrome b reoxidation through center N is prevented, the first ubiquinol oxidation in a monomer would reduce heme b H almost exclusively, and a second turnover would reduce b L . This makes it possible to distinguish spectroscopically between one monomer oxidizing two ubiquinol molecules at center P (resulting in 50% of the absorbance change that would result from total cytochrome b reduction) and two monomers turning over once (resulting in 70% of the maximum possible absorbance change) by using different decyl-ubiquinol concentrations in the presence of antimycin.
However, as shown by the kinetic modeling in Fig. 5B , neither of these two possibilities could account for the extent of cytochrome b reduction in the bc 1 complex from wild-type yeast assayed at pH 8.8. Instead, the experimental data (Fig. 5A) can be simulated assuming that one monomer reduces two b H hemes after turning over twice at center P. This indicates that electrons are transferred to both cytochrome b subunits in the dimer through only one center P, and that electron equilibration between the four b hemes in the dimer is possible. The same result was observed with the bc 1 complex containing iron-sulfur protein with a Y185F mutation (Fig. 6) , which was especially obvious at higher concentrations of decyl-ubiquinol that make the second turnover more evident because of the higher E m of decyl-ubiquinol at pH 7.
Pre-steady State Reduction of Exogenous Cytochrome c-In order to make the second turnover at center P more favorable in the presence of antimycin, cytochrome c was added to the pre-steady state kinetics assays. As shown in Fig. 7 , the bc 1 complex reduces cytochrome c in two distinct phases, which were modeled as corresponding to the concerted oxidation of decyl-ubiquinol (fast phase), and to the unfavorable one electron oxidation of substrate by iron-sulfur protein followed by semiquinone dissociation and dismutation (slow phase). Since the slow phase became significantly fast when more than 4 equivalents of decyl-ubiquinol were present, the kinetics of cytochrome c reduction with a 10-fold excess of substrate was omitted from Fig. 7 . The experimental data points could only be simulated by assuming that only half of the center P sites were active as shown in Fig. 7A , whereas modeling which assumed that all monomers participated in ubiquinol oxidation (Fig. 7B ) resulted in a fast reduction of twice the magnitude as that observed experimentally during the fast phase. Similar results were obtained with the bc 1 complex with the Y185F iron-sulfur protein assayed at pH 7 (Fig. 8) , with the advantage that the slow phase of cytochrome c reduction is less evident, probably because the dismutation of semiquinone is less favorable at pH 7. Cytochrome bc 1 complex from wild-type yeast was suspended at 1.5 M in assay buffer at pH 8.8 and reduced with 15 M decyl-ubiquinol in the stopped flow mixing chamber in the absence (A) or presence (B) of 3 M antimycin, and spectra were recorded after 2 min. A spectrum of the same amount of oxidized bc 1 complex mixed with buffer lacking decyl-ubiquinol was subtracted. The absorbance in the reduced-oxidized spectra (solid lines) was normalized to zero at the reference wavelengths of 539 nm and 579 nm before deconvolution to obtain cytochrome c 1 (dashed curve) and cytochrome b (dotted curve) spectral contributions using a Lorentzian function with two components.
Pre-steady State Reduction of Cytochrome b in the Presence of Antimycin and of Exogenous Cytochrome c-Both
protein, the extent of cytochrome b reduced by decyl-ubiquinol when an excess of oxidant is present could only be simulated assuming half-of-the-sites reactivity at center P and electron crossover between cytochrome b subunits in the dimer (Figs. 9A  and 10A, solid lines) . If the concentration of active enzyme was fixed to 100%, the extent of reduced cytochrome b (Figs. 9B and 10B, solid lines) turned out to be significantly higher than the experimental traces (Figs. 9A and 10A ). On the other hand, eliminating the electron crossover assumption yielded lower levels of reduction (Figs. 9B and 10B, dashed lines) . Interestingly, no slow phase similar to that observed in the cytochrome c kinetics was observed in cytochrome b. This supports the assumption included in the simulation that the slow cytochrome c reduction is not due to a slower concerted oxidation of decyl-ubiquinol, but corresponds instead to the formation of semiquinone. Because two turnovers at one center P per dimer resulting in reduction of two b H hemes are assumed, the model also implies that the unstable semiquinone formed in the presence of antimycin is unable to reduce the available b L heme.
Effect of Antimycin on the Steady-state Reduction of Cytochrome c-Titration of the ubiquinol-cytochrome c reductase activity of the bc 1 complex with antimycin results in nonlinear inhibition curves as shown in Fig. 11A . Notably, a clear stimulation of the activity by ϳ20% is observed and reaches a maximum between 0.2 and 0.3 equivalents of antimycin. Reduction of cytochrome c by superoxide anion formed in the presence of antimycin cannot account for this stimulation or the non-linear shape of the titration curve, since the antimycininsensitive rate of cytochrome c reduction was ϳ10 s Ϫ1 (see data points with 1.1 and 1.2 equivalents of antimycin in Fig.  11A ). This rate is expected to be even lower when antimycin is nonsaturating, which is the case at the concentrations where the stimulation was observed. Furthermore, similar titration curves were obtained in the presence of 140 units of superoxide dismutase and 300 units of catalase, or in an assay medium maintained in anaerobiosis using a glucose oxidase and argon flow oxygen depletion system (25) to eliminate any cytochrome c reduction by superoxide anion (data not shown). A similar stimulation of the steady state activity of the yeast bc 1 complex at low inhibitor/enzyme ratios has been observed with ilicicolin H, another center N inhibitor (26) . Since these effects of antimycin could not be attributed to superoxide anion, the stimulation of the activity and the nonlinearity of the titration curve were modeled taking into account the various species of enzyme-inhibitor complexes possible for a dimeric enzyme and a tightly-bound inhibitor as shown in Fig. 11B . The only combination of species that could fit the experimental data (Fig. 11A, solid line) was that which assumes that the uninhibited dimer (EE) has half the activity of dimer with one antimycin bound per dimer (EEI ϩ EIE). This implies that one of the monomers becomes active upon inhibition of one center N in the dimer, and that center P sites can recycle electrons through a single center N by electron equilibration between the cytochrome b subunits. In contrast, if the dimers containing zero and one antimycin bound are considered as equally active, a non-linear curve without stimulation at low concentrations of inhibitor is obtained (Fig. 11A,  dashed line) . Kinetic simulations using detailed models that incorporate these assumptions yielded similar curves to those obtained by adding the relative concentrations of enzyme-inhibitor species (see Supplemental Data). If each monomer functioned independently, linear inhibition should have been observed (Fig. 11A, dotted line) .
DISCUSSION
The functional relevance of the dimeric structure of the bc 1 complex has long been suspected based on spectroscopic differences in some of the intermediate species and redox cofactors in the enzyme (27) or loss of half the activity upon genetic deletion of the non-catalytic subunit 6 (28) . The recent finding that some center P inhibitors inhibit the enzyme with a titer of 0.5 to 1 also implies anti-cooperative binding between monomers (6). Our present results provide direct evidence of catalytic anti-cooperativity between monomers of the bc 1 complex. We have also shown that the anomalous non-linear titration curves for inhibition of activity by antimycin, which inhibits completely the bc 1 complex with a titer of 1:1, can be explained in terms of a functional dimer.
Previous studies of the pre-steady state kinetics using bc 1 complex at neutral or acidic pH (6, 15, 29) have not revealed the anti-cooperative oxidation of substrate because of the higher E m of iron-sulfur protein with respect to cytochrome c 1 . Under such conditions, cytochrome c 1 is reduced mainly after a second slow and thermodynamically unfavorable substrate oxidation at center P in the presence of antimycin (29) . Consequently, incomplete cytochrome c 1 reduction could be attributed solely to the low equilibrium constant for the second turnover at center P. We have circumvented this difficulty by choosing conditions in which the first turnover is reflected in cytochrome c 1 reduction and which leave iron-sulfur protein largely oxidized and available to catalyze a second ubiquinol oxidation reaction.
At the same time, correcting for the absorbance contribution of cytochrome b at the wavelengths commonly used for cytochrome c 1 quantification has permitted accurately determining the relative amount of active bc 1 complex both in the presence and absence of antimycin. The observation that the absorbance change at 554 versus 539 nm upon ubiquinol oxidation in the presence of antimycin is less than in the uninhibited bc 1 complex has been reported previously (30) , but was attributed to a significantly lower contribution of cytochrome b at this wavelength pair because of the red shift induced by the inhibitor in the b H spectrum. However, we have now determined that the spectral overlap from cytochrome b is of similar magnitude in the presence of antimycin. Moreover, we found that a severalfold excess of decyl-ubiquinol resulted in a decrease in the extent of cytochrome c 1 reduction, that can be explained by ubiquinol binding to center N and reducing heme b H . Thus, if only one of the monomers is assumed to be active in the presence of antimycin, a decrease of exactly 50% in c 1 absorbance is not to be expected when compared with a condition where an excess of substrate is available (30) .
The extent of reduction of cytochrome c 1 in the absence of antimycin reached a maximum of 80%, whereas only up to 50% was reduced when both center N sites in the dimer were blocked. Even when an excess of oxidant such as cytochrome c was available, the presence of antimycin still yielded kinetics that corresponded to only half of the enzyme being active. Analysis of cytochrome b kinetics also support the conclusion that only half of the enzyme is involved in center P catalysis when antimycin is bound to both center N sites. This evidence argues in favor of an alternating half-of-the-sites mechanism by the bc 1 complex, in which only one monomer is able to oxidize ubiquinol at center P at a time. According to our data, if heme b H reoxidation through center N is prevented, ubiquinol oxidation stops after two turnovers have occurred through a single center P. Further evidence showing that there is conformational communication between center N and center P through iron-sulfur protein comes from the increased sensitivity to proteolysis of the hinge or neck region of iron-sulfur protein in the presence of antimycin (31) , and from the finding that antimycin can only bind to half of the bc 1 complex when the Rieske cluster is not assembled into iron-sulfur protein (7) .
Our kinetic modeling of the pre-steady state kinetics of cytochrome b reduction indicates that two b H hemes are reduced after two ubiquinol oxidation turnovers by one active monomer. This implies electron crossover between cytochrome b subunits of the dimer. Structures of bc 1 complexes from various sources (2-4) show an iron-iron and heme edge to edge distance of ϳ21 Ubiquinol-cytochrome c reductase activity of the bc 1 complex from wildtype yeast was measured in the presence of various amounts of antimycin and is shown in A (solid circles). The dotted curve represents the expected initial rates assuming only antimycin-free monomers (E) are active. The dashed curve is the simulation of initial rates assuming that dimers with no inhibitor bound (EE) and those with one antimycin bound (EEI, EIE) contribute equally to the activity. The solid curve is the simulation of initial rates assuming that dimers with one molecule of antimycin bound (EEI, EIE) are twice as active as the free dimer (EE). B shows the relative concentration of all possible free enzyme or enzyme-inhibitor complexes from which the curves shown in A were obtained.
Å and ϳ11 Å, respectively, between the b L hemes of the dimer, consistent with non-rate-limiting electron transfer. In contrast, the corresponding distances between the b H hemes are over 30 Å, suggesting that intradimeric electron transfer occurs through heme b L . Notably, no further catalysis was possible through the active center P once the second b H heme became reduced, even though both b L hemes were oxidized. This is consistent with our interpretation that only one iron-sulfur protein and cytochrome c 1 per dimer are available to accept electrons from ubiquinol, bringing the reaction to a stop after only two turnovers. However, even when cytochrome c is available to oxidize cytochrome c 1 and iron-sulfur protein, no more than two turnovers are possible. This indicates that having both b H hemes reduced abolishes concerted ubiquinol oxidation at center P, although the slow formation of semiquinone by reduction of iron-sulfur protein is still possible. Electrostatic effects preventing b L reduction when b H is reduced (32) or conformational changes in the ubiquinol binding site which prevent electron transfer to heme b L could explain this observation.
The kinetic model that best fitted the cytochrome c reductase activity as a function of antimycin concentration also assumes electron crossover between monomers. Furthermore, this mechanism implies that both center P sites become active simultaneously when antimycin is blocking only one center N in the dimer. The nonlinear inhibition of the steady-state activity with antimycin has been previously modeled in terms of rapid inhibitor mobility between monomers (10). Even though crystal structures show a continuous cavity from center N of one monomer to center P of the other (2-4), no connecting empty space exists between center N sites that would allow movement of antimycin directly between monomers. Only two hydrophobic clefts for the entrance and exit of ligands are observed, and both of them are open to the interior of the membrane. The low dissociation constant for a tightly bound inhibitor such as antimycin (8) argues against such rapid movement. Moreover, our kinetic simulations show that even if one antimycin molecule was able to move between monomers, linear inhibition curves should still be observed (Supplemental Data).
Our results show that symmetric occupancy of center N induces asymmetric activity at center P. In agreement with this finding, it has been reported that the inactivation of both center P sites by failure to insert the Rieske cluster results in asymmetry of center N activity (7) . The physiological relevance of this mechanism could reside in the ability of the bc 1 complex to sense ubiquinol/ubiquinone ratios through center N. Increases in this ratio would induce activation of the silent half of the center P sites to contend with the excess of reducing equivalents, a condition analogous to that observed with one antimycin bound per dimer. At even higher ubiquinol/ubiquinone ratios half of the enzyme could be inactivated again to decrease semiquinone and reactive oxygen species formation at center P, as observed when two antimycin molecules are bound to the dimer, or when high ubiquinol concentrations are used to reduce the enzyme.
